O24.41 Gestational diabetes mellitus in pregnancy

Name of the Condition

• Gestational diabetes mellitus in pregnancy (O24.41)

Summary

This condition refers to glucose intolerance that is first recognized during pregnancy and is not overt diabetes prior to gestation. It typically develops in the second or third trimester due to hormonal changes that increase insulin resistance. Management focuses on controlling blood glucose levels to reduce risks to the mother and fetus.

Causes

Gestational diabetes occurs when pregnancy-related hormones (e.g., human placental lactogen, progesterone) impair insulin sensitivity, overwhelming the pancreas’ ability to produce sufficient insulin. Risk increases as pregnancy progresses, particularly in the second and third trimesters, when insulin resistance peaks.

Risk Factors

• Obesity (BMI ≥30) or excessive weight gain before pregnancy.
• Advanced maternal age (≥35 years).
• Family history of type 2 diabetes.
• Previous gestational diabetes in a prior pregnancy.
• Polycystic ovary syndrome (PCOS).
• Ethnicity (higher prevalence in Hispanic, African American, Asian, or Native American populations).
• History of delivering a large-for-gestational-age infant or unexplained stillbirth.

Symptoms

• Increased thirst (polydipsia) and urination (polyuria).
• Fatigue.
• Blurred vision.
• Recurrent infections (e.g., yeast infections).
• Nausea or vomiting (may overlap with pregnancy symptoms).

Diagnosis

Diagnosis is confirmed through screening and diagnostic testing, typically performed between 24–28 weeks of gestation. Initial screening uses a 50g oral glucose challenge test (OGCT), followed by a 100g oral glucose tolerance test (OGTT) if results are abnormal. Criteria include elevated fasting or postprandial glucose levels meeting established thresholds.

Treatment Options

• Diet and exercise: Individualized meal plans and moderate physical activity to maintain target blood glucose levels.
• Blood glucose monitoring: Self-monitoring of blood glucose (SMBG) to track fasting and postprandial levels.
• Medication: Insulin therapy or oral agents (e.g., metformin, glyburide) if lifestyle modifications fail to achieve glycemic control.
• Fetal monitoring: Regular ultrasounds and non-stress tests to assess fetal growth and well-being.

Prognosis and Follow-Up

Most women with gestational diabetes have normal glucose levels postpartum, but they face a higher risk of developing type 2 diabetes later in life. Postpartum glucose testing (e.g., 75g OGTT at 6–12 weeks) is recommended to rule out preexisting diabetes. Long-term follow-up includes regular screening for diabetes and cardiovascular risk factors.

Complications

• Maternal: Preeclampsia, cesarean delivery, and future type 2 diabetes.
• Fetal/Neonatal: Macrosomia (large birth weight), shoulder dystocia, hypoglycemia, jaundice, and increased risk of childhood obesity or type 2 diabetes.

Lifestyle & Prevention

• Maintain a healthy pre-pregnancy weight and balanced diet.
• Engage in regular moderate exercise (e.g., walking) before and during pregnancy.
• Monitor weight gain according to gestational guidelines.
• Attend prenatal care to enable early screening and intervention.

When to Seek Professional Help

Seek care if experiencing symptoms of hyperglycemia (e.g., excessive thirst, frequent urination) or if blood glucose levels are consistently above target ranges. Immediate medical attention is needed for signs of preeclampsia (e.g., severe headache, swelling) or fetal movement changes.

Tips for Medical Coders

Document the timing of diagnosis (e.g., trimester of onset), results of glucose testing, and any interventions (e.g., insulin use, dietary counseling). Ensure differentiation from pregestational diabetes by confirming no prior diabetes history. Code O24.41 is specific to gestational diabetes; do not use for preexisting diabetes in pregnancy.